Glenn Dranoff

Person

Lexington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for immunooncology
- Patent number 12,037,583
- Issue date Jul 16, 2024
- Novartis AG
- Ming-Wei Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination vaccine devices and methods of killing cancer cells
- Patent number 11,998,593
- Issue date Jun 4, 2024
- President and Fellows of Harvard College
- Omar Abdel-Rahman Ali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NKG2D-IG fusion protein for cancer immunotherapy
- Patent number 11,851,472
- Issue date Dec 26, 2023
- Dana-Farber Cancer Institute, Inc.
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor suppressor and oncogene biomarkers predictive of anti-immune...
- Patent number 11,624,093
- Issue date Apr 11, 2023
- Dana-Farber Cancer Institute, Inc.
- Kwok-Kin Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for reducing immunosuppression by tumor cells
- Patent number 11,597,934
- Issue date Mar 7, 2023
- Dana-Farber Cancer Institute, Inc.
- Kai W. Wucherpfennig
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunomodulation by IAP inhibitors
- Patent number 11,382,905
- Issue date Jul 12, 2022
- Novartis AG
- Leigh Zawel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for reducing immunosupression by tumor cells
- Patent number 10,876,120
- Issue date Dec 29, 2020
- Dana-Farber Cancer Institute, Inc.
- Kai W. Wucherpfennig
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
NKG2D-IG fusion protein for cancer immunotherapy
- Patent number 10,865,232
- Issue date Dec 15, 2020
- Dana-Farber Cancer Institute, Inc.
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NKG2D-fc for immunotherapy
- Patent number 10,865,233
- Issue date Dec 15, 2020
- Dana-Farber Cancer Institute, Inc.
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody molecules to PD-L1 and methods of treating cancer
- Patent number 10,851,165
- Issue date Dec 1, 2020
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic peptides
- Patent number 10,793,633
- Issue date Oct 6, 2020
- Dana-Farber Cancer Institute, Inc.
- Kai W. Wucherpfennig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunomodulation by IAP inhibitors
- Patent number 10,786,491
- Issue date Sep 29, 2020
- Novartis AG
- Leigh Zawel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic peptides
- Patent number 10,745,483
- Issue date Aug 18, 2020
- Dana-Farber Cancer Institute, Inc.
- Kai W. Wucherpfennig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination vaccine devices and methods of killing cancer cells
- Patent number 10,682,400
- Issue date Jun 16, 2020
- President and Fellows of Harvard College
- Omar Abdel-Rahman Ali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use for augmented immune response and c...
- Patent number 10,662,247
- Issue date May 26, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of eliciting an anti-tumor immune response with controlled d...
- Patent number 10,568,949
- Issue date Feb 25, 2020
- President and Fellows of Harvard College
- Omar Abdel-Rahman Ali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Continuous cell programming devices
- Patent number 10,328,133
- Issue date Jun 25, 2019
- President and Fellows of Harvard College
- David J. Mooney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccine compositions and methods for restoring NKG2D pathway functi...
- Patent number 10,279,021
- Issue date May 7, 2019
- Dana-Faber Cancer Institute, Inc.
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Continuous cell programming devices
- Patent number 10,258,677
- Issue date Apr 16, 2019
- President and Fellows of Harvard College
- David J. Mooney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of attenuating reactions to skin irritants
- Patent number 10,226,476
- Issue date Mar 12, 2019
- Dana-Farber Cancer Institute, Inc.
- S. Brian Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that bind to MHC class I polypeptide-related sequence A
- Patent number 10,106,611
- Issue date Oct 23, 2018
- Dana-Farber Cancer Institute, Inc.
- Kai W. Wucherpfennig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to PD-L1 and uses thereof
- Patent number 9,988,452
- Issue date Jun 5, 2018
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for reducing immunosupression by tumor cells
- Patent number 9,944,931
- Issue date Apr 17, 2018
- Dana-Farber Cancer Institute, Inc.
- Kai W. Wucherpfennig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Controlled delivery of TLR3 agonists in structural polymeric devices
- Patent number 9,821,045
- Issue date Nov 21, 2017
- President and Fellows of Harvard College
- Omar Abdel-Rahman Ali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunomodulation by IAP inhibitors
- Patent number 9,750,729
- Issue date Sep 5, 2017
- Dana-Farber Cancer Institute, Inc.
- Leigh Zawel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor immunity
- Patent number 9,492,518
- Issue date Nov 15, 2016
- Dana-Farber Cancer Institute, Inc.
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic peptides
- Patent number 9,402,905
- Issue date Aug 2, 2016
- Dana-Farber Cancer Institute, Inc.
- Kai W. Wucherpfennig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Controlled delivery of TLR agonists in structural polymeric devices
- Patent number 9,370,558
- Issue date Jun 21, 2016
- President and Fellows of Harvard College
- Omar Abdel-Rahman Ali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of attenuating reactions to skin irritants
- Patent number 7,419,958
- Issue date Sep 2, 2008
- Dana-Farber Cancer Institute, Inc.
- S. Brian Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor antigens and uses thereof
- Patent number 7,250,291
- Issue date Jul 31, 2007
- Dana Farber Cancer Institute
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
- Publication number 20240417722
- Publication date Dec 19, 2024
- Novartis AG
- Ming-Wei CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFE...
- Publication number 20240343808
- Publication date Oct 17, 2024
- Novartis AG
- Gordon James Freeman
- G01 - MEASURING TESTING
Information Patent Application
DOSING REGIMEN AND PHARMACEUTICAL COMBINATION COMPRISING 3-(1-OXOIS...
- Publication number 20240245670
- Publication date Jul 25, 2024
- Novartis AG
- Simone BONAZZI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NKG2D-IG FUSION PROTEIN FOR CANCER IMMUNOTHERAPY
- Publication number 20240190942
- Publication date Jun 13, 2024
- Dana-Farber Cancer Institute, Inc.
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES...
- Publication number 20240139244
- Publication date May 2, 2024
- Novartis AG
- Glenn Dranoff
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods and Compositions for Reducing Immunosupression by Tumor Cells
- Publication number 20230383298
- Publication date Nov 30, 2023
- Dana-Farber Cancer Institute, Inc.
- Kai W. Wucherpfennig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
- Publication number 20230174933
- Publication date Jun 8, 2023
- Novartis AG
- Jennifer BROGDON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO CD73 AND USES THEREOF
- Publication number 20230039109
- Publication date Feb 9, 2023
- Novartis AG
- Bianka Prinz
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1
- Publication number 20230013364
- Publication date Jan 19, 2023
- Novartis AG
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
- Publication number 20220364055
- Publication date Nov 17, 2022
- Novartis AG
- Louise Treanor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immunomodulation by IAP Inhibitors
- Publication number 20220296581
- Publication date Sep 22, 2022
- Novartis AG
- Leigh ZAWEL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3
- Publication number 20220153835
- Publication date May 19, 2022
- Novartis AG
- Glenn DRANOFF
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220133889
- Publication date May 5, 2022
- Novartis AG
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NKG2D-FC FOR IMMUNOTHERAPY
- Publication number 20220002382
- Publication date Jan 6, 2022
- Dana-Farber Cancer Institute, Inc.
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF
- Publication number 20210284737
- Publication date Sep 16, 2021
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
- Publication number 20210220404
- Publication date Jul 22, 2021
- Novartis AG
- Aida Abujoub
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO CD73 AND USES THEREOF
- Publication number 20210214459
- Publication date Jul 15, 2021
- Novartis AG
- Ansgar Brock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Compositions for Reducing Immunosupression by Tumor Cells
- Publication number 20210139914
- Publication date May 13, 2021
- Dana-Farber Cancer Institute, Inc.
- Kai W. Wucherpfennig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NKG2D-IG FUSION PROTEIN FOR CANCER IMMUNOTHERAPY
- Publication number 20210130434
- Publication date May 6, 2021
- Dana-Farber Cancer Institute, Inc.
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
- Publication number 20210123075
- Publication date Apr 29, 2021
- Novartis AG
- Ming-Wei CHEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND C...
- Publication number 20210015860
- Publication date Jan 21, 2021
- Novartis AG
- Jennifer BROGDON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immunomodulation by IAP Inhibitors
- Publication number 20200345714
- Publication date Nov 5, 2020
- Dana-Farber Cancer Institute, Inc.
- Leigh ZAWEL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES...
- Publication number 20200281973
- Publication date Sep 10, 2020
- Novartis AG
- Glenn Dranoff
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION VACCINE DEVICES AND METHODS OF KILLING CANCER CELLS
- Publication number 20200276290
- Publication date Sep 3, 2020
- President and Fellows of Harvard College
- Omar Abdel-Rahman Ali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES
- Publication number 20200277378
- Publication date Sep 3, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO CD73 AND USES THEREOF
- Publication number 20200172628
- Publication date Jun 4, 2020
- Novartis AG
- Viviana Cremasco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO CD73 AND USES THEREOF
- Publication number 20190031766
- Publication date Jan 31, 2019
- Novartis AG
- Bianka Prinz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
- Publication number 20180371093
- Publication date Dec 27, 2018
- Novartis AG
- Sanela Bilic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
- Publication number 20180362975
- Publication date Dec 20, 2018
- Novartis AG
- Ming-Wei CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AN NKG2D-IG FUSION PROTEIN FOR CANCER IMMUNOTHERAPY
- Publication number 20180355013
- Publication date Dec 13, 2018
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Glenn Dranoff

Person

Patents Grantslast 30 patents

Compositions and methods for immunooncology

Combination vaccine devices and methods of killing cancer cells

NKG2D-IG fusion protein for cancer immunotherapy

Tumor suppressor and oncogene biomarkers predictive of anti-immune...

Methods and compositions for reducing immunosuppression by tumor cells

Immunomodulation by IAP inhibitors

Methods and compositions for reducing immunosupression by tumor cells

NKG2D-IG fusion protein for cancer immunotherapy

NKG2D-fc for immunotherapy

Antibody molecules to PD-L1 and methods of treating cancer

Therapeutic peptides

Immunomodulation by IAP inhibitors

Therapeutic peptides

Combination vaccine devices and methods of killing cancer cells

Compositions and methods of use for augmented immune response and c...

Method of eliciting an anti-tumor immune response with controlled d...

Continuous cell programming devices

Vaccine compositions and methods for restoring NKG2D pathway functi...

Continuous cell programming devices

Method of attenuating reactions to skin irritants

Antibodies that bind to MHC class I polypeptide-related sequence A

Antibody molecules to PD-L1 and uses thereof

Methods and compositions for reducing immunosupression by tumor cells

Controlled delivery of TLR3 agonists in structural polymeric devices

Immunomodulation by IAP inhibitors

Tumor immunity

Therapeutic peptides

Controlled delivery of TLR agonists in structural polymeric devices

Method of attenuating reactions to skin irritants

Tumor antigens and uses thereof

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFE...

DOSING REGIMEN AND PHARMACEUTICAL COMBINATION COMPRISING 3-(1-OXOIS...

NKG2D-IG FUSION PROTEIN FOR CANCER IMMUNOTHERAPY

CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES...

Methods and Compositions for Reducing Immunosupression by Tumor Cells

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

ANTIBODY MOLECULES TO CD73 AND USES THEREOF

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

Immunomodulation by IAP Inhibitors

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

NKG2D-FC FOR IMMUNOTHERAPY

ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

ANTIBODY MOLECULES TO CD73 AND USES THEREOF

Methods and Compositions for Reducing Immunosupression by Tumor Cells

NKG2D-IG FUSION PROTEIN FOR CANCER IMMUNOTHERAPY

COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND C...

Immunomodulation by IAP Inhibitors

CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES...

COMBINATION VACCINE DEVICES AND METHODS OF KILLING CANCER CELLS

COMBINATION THERAPIES

ANTIBODY MOLECULES TO CD73 AND USES THEREOF

ANTIBODY MOLECULES TO CD73 AND USES THEREOF

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

AN NKG2D-IG FUSION PROTEIN FOR CANCER IMMUNOTHERAPY